[
  {
    "ts": null,
    "headline": "NTLA Declines 67% in a Month: Should You Buy, Sell or Hold the Stock?",
    "summary": "Intellia sinks 67% in a month after a clinical hold on nex-z and mixed third-quarter results, raising questions about its pipeline outlook and near-term direction.",
    "url": "https://finnhub.io/api/news?id=84d74cb8df67ca98433d4dae1cc21456bdc84806d452e50bc79af1b63a82ca0d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763738340,
      "headline": "NTLA Declines 67% in a Month: Should You Buy, Sell or Hold the Stock?",
      "id": 137572451,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Intellia sinks 67% in a month after a clinical hold on nex-z and mixed third-quarter results, raising questions about its pipeline outlook and near-term direction.",
      "url": "https://finnhub.io/api/news?id=84d74cb8df67ca98433d4dae1cc21456bdc84806d452e50bc79af1b63a82ca0d"
    }
  },
  {
    "ts": null,
    "headline": "This Month's Stock Trend Hasn't Been AI. Here's What's Been Climbing Instead",
    "summary": "Healthcare stocks have outperformed the broader market by nearly 10 percentage points this month as AI bubble concerns have weighed on tech stocks.",
    "url": "https://finnhub.io/api/news?id=aeb9f425345bd2c5b14be30c17961db77f7d63f64a9cceb66a8893c1fdc0b773",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763738158,
      "headline": "This Month's Stock Trend Hasn't Been AI. Here's What's Been Climbing Instead",
      "id": 137572013,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Healthcare stocks have outperformed the broader market by nearly 10 percentage points this month as AI bubble concerns have weighed on tech stocks.",
      "url": "https://finnhub.io/api/news?id=aeb9f425345bd2c5b14be30c17961db77f7d63f64a9cceb66a8893c1fdc0b773"
    }
  },
  {
    "ts": null,
    "headline": "Are Wall Street Analysts Bullish on Regeneron Pharmaceuticals Stock?",
    "summary": "Regeneron Pharmaceuticals has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=0a235255ad02b2b1b7c2192c2e6eac97d93a7452068f3fdf39f0308007e0024b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763733175,
      "headline": "Are Wall Street Analysts Bullish on Regeneron Pharmaceuticals Stock?",
      "id": 137572453,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=0a235255ad02b2b1b7c2192c2e6eac97d93a7452068f3fdf39f0308007e0024b"
    }
  },
  {
    "ts": null,
    "headline": "3 Nasdaq 100 Stocks We Keep Off Our Radar",
    "summary": "The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing growth, increasing competition, or unsustainable valuations.",
    "url": "https://finnhub.io/api/news?id=fecefe9866f955cfc62b2e811e2f987aede6dd4f94cdf9611d11522c99cd2021",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763732203,
      "headline": "3 Nasdaq 100 Stocks We Keep Off Our Radar",
      "id": 137572454,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing growth, increasing competition, or unsustainable valuations.",
      "url": "https://finnhub.io/api/news?id=fecefe9866f955cfc62b2e811e2f987aede6dd4f94cdf9611d11522c99cd2021"
    }
  }
]